% Expired Patents = 100.0

EPO Patents = 2

Forward Citations = 31

Loading Chart...

9 inventors (with patents filed for the assignee):

Frank Striggow (2 out of 6 patents)

Siegfried Ansorge (2 out of 10 patents)

Klaus G Reymann (1 out of 2 patents)

4. Ute Bank (1 out of 2 patents)

5. Michael Täger (1 out of 3 patents)

6. Karsten Nordhoff (1 out of 1 patent)

7. Michael Taeger (1 out of 2 patents)

8. Peter Röhnert (1 out of 2 patents)

9. Ulrich Schröder (1 out of 1 patent)

10. Till Mack (4 patents)

11. Uwe; Inst Exp Innere Medizin Lendeckel (0 patent)

12. Frank Keyneurotek Ag iG Striggow (0 patent)

13. Klaus Martin-Luther-Uni Biochemie/Biotech Neubert (0 patent)

14. Thilo Kähne (0 patent)

15. Klaus; c/o FAN Gmbh Reymann (0 patent)

2 patents: Sort by Forward Citations

1. 8263636 - Dual alanyl aminopeptidase and dipeptidyl peptidase iv inhibitors for functionally influencing different cells and for treating immunological inflammatory, neuronal and other diseases (2012-09-11),

2. 7858655 - Drug preparation comprising α-lipoic acid, ambroxol and/or inhibitors of the angiotensin-converting enzyme (ACE) and its use for the treatment of neurodegenerative diseases (2010-12-28),

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

2 Patents

#15 in Magdeburg

#10,696 in Germany

Magdeburg, Germany

Keyneurotek Pharmaceuticals Ag

Forward Citations = 31

9 inventors:

Frank Striggow (2 out of 6 patents)

Siegfried Ansorge (2 out of 10 patents)

Klaus G Reymann (1 out of 2 patents)

4. Ute Bank (1 out of 2 patents)

5. Michael Täger (1 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Keyneurotek Pharmaceuticals Ag. Retrieved from https://idiyas.com/company/keyneurotek-pharmaceuticals-ag

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]